The efficacy of ogikeishigomotsuto on chronic cumulative sensory neuropathy induced by Oxaliplatin - Case report and Literature view-

Journal of Traditional Medicines

Volumn 26, Issue 3, 2009, Pages 136-140

  Tatsumi, Takeshi ^a   Kishi, Daijiro ^a   Kogure, Toshiaki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Kampo; neuropathy; ogikeishigomotsuto; Oxaliplatin

Indexed keywords

EID: 85012197591     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.26.136     Document Type: Article

References (23)

1. de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., Papamichael, D., Le Bail, N., Louvet, C., Hendler, D., de Braud, F., Wilson, C., Morvan, F. and Bonetti, A.: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol., 18, 2938-2947, 2000.
2. Tournigand, C., Cervantes, A., Figer, A., Lledo, G., Flesch, M., Buyse, M., Mineur, L., Carola, E., Etienne, PL., Rivera, F., Chirivella, I., Perez-Staub, N., Louvet, C., André, T., Tabah-Fisch, I. and de Gramont, A.: OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. J. Clin. Oncol., 24, 394-400, 2006.
3. Extra, JM., Marty, M., Brienza, S. and Misset, JL.: Pharmacokinetics and safety profile of oxaliplatin. Semin. Oncol., 25, 13-22, 1998.
4. Gamelin, L., Boisdron-Celle, M., Delva, R., Guérin-Meyer, V., Ifrah, N., Morel, A. and Gamelin, E.: Prevention of oxaliplatin-related neurotoxicity by calcium magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin. Cancer. Res., 10, 4055-4061, 2004.
5. Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, AM., Beretta, GD., Ubiali, E. and Catalano, G.: Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo controlled trial. J. Clin. Oncol., 16, 3478-3483, 2002.
6. Lersch, C., Schmelz, R., Eckel, F., Erdmann, J., Mayr, M., Schulte-Frohlinde, E., Quasthoff, S., Grosskreutz, J. and Adelsberger, H.: Prevention of oxaliplatin neuropathy by carbamazepine. A pilot study. Dtsch. Med. Wochenschr., 127, 78-82, 2003.
7. Penz, M., Kornek, GV., Raderer, M., Ulrich-Pur, H., Fiebiger, W. and Scheithauer, W.: Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy. Ann. Oncol., 12, 421-422, 2001.
8. Marshall, J., Zakari, A. and Hwang, J.: Ginkgo Biloba (GB) extract as a neuroprotective agent in oxaliplatin (Ox)-induced neuropathy [abstract]. J. Clin. Oncol., 22, 3670, 2004.
9. Mamiya, N., Kono, T., Mamiya, K., Satomi, M., Chisato, N. and Ebisawa, Y.: A case of neurotoxicity reduced with Gosha-ginki-gan in modified FOLFOX6 chemotherapy for advanced colon cancer. Jpn. J. Cancer Chemother., 34, 1295-1297, 2007.
10. Shindo, Y., Tenma, K., Imano, H., Hibino, M., Yoshino, K. and Nakamura, M.: Reduction of oxaliplatin-related neurotoxicity by Gosya-ginki-gan. Jpn. J. Cancer Chemother., 35, 863-865, 2008.
11. Colon and rectum. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, Springer, pp.113-124, 2002.
12. Terasawa, K.: KAMPO Japanese-oriental medicine. Standard McIntyre, Tokyo, pp.260, 1994.
13. The Japan Society for Oriental Medicine.: Precautionary instruction. In Introduction to KAMPO. Elsevier, Tokyo, pp.18-62, 2005.
14. Yamamoto, T., Murai, T., Ueda, M., Katsuura, M., Oishi, M., Miwa, Y., Okamoto, Y., Uejima, E., Taguchi, T., Noguchi, S. and Kurokawa, N.: Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosha-jinki-gan. Gan To Kagaku Ryoho. 36, 89-92, 2009.
15. Li, Y., Cui, HJ., Huang, JC., Wu, XQ.: Clinical study of Jiawei Huanggi Guizhi Wuwu Decoction in preventing and treating peripheral neuro-sensory toxicity caused by oxaliplatin. Chin J Integr Med., 12, 19-23, 2006.
16. Mitani, K., Wakayama, I., Yoshida, S., Yase, Y., Uebayashi, Y., Mitani, W.: Effect of Long-term Administration of Chinese Herbs in SMON patients. -Especially on Cinnamon and Astragulius Five Herbs Combination (Ogi-Keishi-Gomotsu-To)-. Japanese journal of oriental medicine (Kampo Med.), 40, 83-98, 1989.
17. Furuya, Y., Tanikawa, K., Tatsuno, Y. and Terasawa, K.: Three case reports of dysesthesia successfully treated with Ougikeishi-gomotsu-to. Kampo Med. 55, 131-138, 2004.
18. Oka, H., Inutsuka, H., Nagamine, K., Nogami, T., Kainuma, M., Kimura, H. and Mitsuma, T.: Subjective symptoms that can be indicators for choosing Ogikeishigomotsuto. Kampo Med. 56, 947-951, 2005.
19. Hikiami, H., Yagi, K., Nakata, S., Oka, H., Goto, H., Shibahara, N. and Shimada, Y.: Two cases of numbness and pain of neuropathy due to ANCA-associated vasculitis successfully treated with Ogikeishigomotsuto. Kampo Med., 58, 495-501, 2007.
20. Yu, J., Zhang, Y., Sun, S., Shen, J., Qiu, J., Yin, X., Yin, H. and Jiang, S.: Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can J Physiol Pharmacol. 84, 579-587, 2006.
21. Adelsberger, H., Quasthoff, S., Grosskreutz, J., Lepier, A., Eckel, F. and Lersch, C.: The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons. Euro. J. Pharmacol., 406, 25-32, 2000.
22. Cavaletti, G., Tredici, G., Petruccioli, MG., Dondè, E., Tredici, P., Marmiroli, P., Minoia, C., Ronchi, A., Bayssas, M. and Etienne, GG.: Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer, 37, 2457-2463, 2001.
23. Kannarkat, G., Lasher, EE. and Schiff, D.: Neurologic complications of chemotherapy agents. Curr. Opin. Neurol., 20, 719-725, 2007.